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Abstract
Background: Spinal radiosurgery is a quickly evolving technique in the radiotherapy and neurosurgical
communities. However, the methods of spine radiosurgery have not been standardized. This article describes the
results of a survey about the methods of spine radiosurgery at five international institutions.
Methods: All institutions are members of the Elekta Spine Radiosurgery Research Consortium and have a
dedicated research and clinical focus on image-guided radiosurgery. The questionnaire consisted of 75 items
covering all major steps of spine radiosurgery.
Results: Strong agreement in the methods of spine radiosurgery was observed. In particular, similarities were
observed with safety and quality assurance playing an important role in the methods of all institutions,
cooperation between neurosurgeons and radiation oncologists in case selection, dedicated imaging for target- and
organ-at-risk delineation, application of proper safety margins for the target volume and organs-at-risk, conformal
planning and precise image-guided treatment delivery, and close clinical and radiological follow-up. In contrast,
three major areas of uncertainty and disagreement were identified: 1) Indications and contra-indications for spine
radiosurgery; 2) treatment dose and fractionation and 3) tolerance dose of the spinal cord.
Conclusions: Results of this study reflect the current practice of spine radiosurgery in large academic centers.
Despite close agreement was observed in many steps of spine radiosurgery, further research in form of
retrospective and especially prospective studies is required to refine the details of spinal radiosurgery in terms of
safety and efficacy.
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Background
Radiotherapy is a well-established treatment for painful
vertebral metastases. Multiple prospective studies report
pain response rates of 50 to 90% [1-4]. Based on rando-
mized studies, no differences in pain response have been
observed between the various fractionation schemes that
r a n g ef r o m4 0G yi n2 0f r a c t i o n st o8G yi nas i n g l e
fraction [5,6].
D e s p i t et h el a c ko fad o s er e s p o n s er e l a t i o n s h i pf o r
pain control, there is good rationale for high dose
escalation beyond those conventional dose levels tested
with the aim to improve upon existing rates of local and
pain control. The median duration of pain response
after conventional palliative radiotherapy is approxi-
mately 3 to 6 months, again without differences between
the different fractionation schemes [1-4]. Only short pal-
liation after conventional radiotherapy seems to be the
case especially for unfavorable histologies (lung, kidney,
head & neck and gastrointestinal cancer, melanoma, sar-
coma) as observed in a randomized trial for metastatic
spinal cord compression [7]. This brief palliative effect
may be sufficient for some patients with very short life
expectancy. However, several predictive scores have
been reported, which allow selection of patients with
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chemotherapy may further prolong life expectancy,
long-term palliation and long-term tumor control
become even more important goals for patients despite
having metastatic disease.
As a consequence, there is currently large interest in
intensification of radiotherapy for painful vertebral
metastases. A recent survey from the Unites States
reported that 64% of the radiation oncologists practice
stereotactic body radiotherapy (SBRT) and treatment of
vertebral metastases was the second most common dis-
ease site (67.5% of all SBRT users) [11]. Spine SBRT was
practiced most frequently as single fraction radiosurgery
w i t hd o s e so f2 0G yo r1 8G y .T h em o s tf r e q u e n t l y
cited reasons for practice of SBRT were the possibility
of dose-intensified treatment and re-irradiation. In the
remainder of this manuscript, we will use the term
radiosurgery for both single-fraction and multiple-frac-
tion SBRT as the techniques of the entire treatment
processes are identical between both.
Multiple retrospective and few prospective studies
have reported promising results for spine radiosurgery
with low rates of toxicity and pain control as well as
local tumor control rates consistently ranging between
70 - 90% [12-18]. Importantly, the risk of permanent
spinal cord damage secondary to radiation induced mye-
lopathy has been reported as very low. Despite these
promising data, recent reviews have pointed out the lack
of uniformity in practice [19-21], and currently the com-
munity has no standard approach to the practice of
spine radiosurgery. For example, there is variability in
the treatment techniques, the total dose prescribed to
the tumor, number of fractions, criteria for plan accep-
tance and the dose limits used to the organs at risk.
One recent advance in providing guidance and unifor-
mity to the practice of spine radiosurgery has been the
RTOG phase II/III trial that is currently accruing in the
US (RTOG 0631); however, results of this trial will not
be available in the near future.
The purpose of our study is to give a broad and com-
prehensive overview of the current methods of spine
radiosurgery by surveying experienced practitioners. Five
institutions, all members of the international Elekta
Spine Radiosurgery Research Consortium, answered a
questionnaire with detailed questions about all steps of
spine radiosurgery from indication to follow-up. All cen-
ters used identical equipment for treatment delivery
(Elekta Synergy S linacs all equipped with cone-beam
and robotic HexaPOD technology), which facilitates
methods comparison between the institutions.
Methods
The Elekta Spine Radiosurgery Research Consortium
(ESRRC) is an international research consortium
consisting of five institutions, all of them with a research
and clinical focus on image-guided high precision radio-
therapy in general and spine radiosurgery in particular.
Four of five institutions are academic hospitals (Univer-
sity Hospital Wuerzburg [UHW], Wuerzburg, Germany;
Princess Margaret Hospital (PMH) and the Sunnybrook
Health Sciences Center (SHSC) of the University of Tor-
onto [UofT], Toronto, Canada; University of Pittsburgh
Medical Center [UPMC], Pittsburgh, US; University of
Virginia Medical Center [UVAMC], Charlottesville, US)
and one is a private radiotherapy center fully specialized
in image-guided radiosurgery (Riverside Regional Medi-
cal Center [RSMC], Newport News, US). All institutions
have treated more than 50 patients with vertebral
metastases using image-guided radiosurgery and all aca-
demic centers have contributed to the recent technical
and clinical progress in spine SBRT.
Each center uses identical equipment for delivery of
spine radiosurgery: treatment is planned for a high-reso-
lution multi-leaf collimator with 4 mm leaf width (Beam
modulator on Elekta Synergy S linear accelerator; Elekta,
Crawley, UK), daily volumetric image-guidance is per-
formed with cone-beam technology (Elekta XVI, Crawley,
UK), set-up errors are corrected in six degrees of freedom
(HexaPOD; Medical Intelligence, Schwabmuenchen) and
all patients are immobilized in the BodyFIX system
(Medical Intelligence, Schwabmuenchen, Germany).
A questionnaire with 75 items was established cover-
ing all major aspects of spine radiosurgery including:
indications for spine radiosurgery, imaging required for
treatment planning, target and organ-at-risk (OAR) defi-
nition, treatment planning, dose and fractionation, toler-
ance doses for OARs, patient positioning and image-
guidance, follow-up and response evaluation. Re-irradia-
tion and post-operative radiosurgery was not evaluated
in this questionnaire. The questionnaires were answered
by the responsible physician from each institution and
reflect their current practice of spinal radiosurgery.
Results
Indication for spine radiosurgery
Rationales for the practice of spine radiosurgery com-
pared to conventional palliative radiotherapy are similar
between the five institutions: all agree on more durable
pain control and long-term local tumor control. Four
institutions state a more rapid pain relief as reason for
spine radiosurgery (UPMC, UofT, UVAMC, RSMC),
three institutions explicitly mention spine radiosurgery
for radio-resistant histologies (UHW, UVAMC, UofT),
two institutions use spine radiosurgery because of better
patient convenience (UPMC, RSMC) and one institution
describes the potential of improved overall survival in
the oligometastatic setting as reason for spine radiosur-
gery (UHW). Radiosensitive histologies are excluded in
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mance status is required in all institutions (table 1). All
four academic centers perform spine radiosurgery in the
framework of a prospective protocol but not as a pro-
spective trial.
In contrast, patient selection with respect to estimated
live expectancy is substantially different: one institution
strictly selects patients with good life expectancy using a
predictive scoring system for overall survival (UHW),
two centers exclude patients with very poor life expec-
tancy (UofT, UVAMC) and life expectancy is no rele-
vant factor for two institutions (UPMC, RSMC).
Characteristics of metastatic lesions treated with spine
radiosurgery
The inclusion and exclusion criteria of vertebral metas-
tasis treated with spine radiosurgery are described in
table 2. There is agreement that the relationship
between the target volume and any OAR other than the
spinal cord does not influence the indication for spine
radiosurgery. Both lytic and sclerotic lesions are treated
and all institutions but one (UHW) prefer a stabilization
procedure prior to radiosurgery in cases of spinal
instability. Compression fractures are always discussed
with the neurosurgeon/spine surgeon and symptomatic
spinal cord compression is a contraindication in all
institutions. All vertebras in the cervical, thoracic and
lumbar spine are treated and the number of vertebras
within one target volume is limited to 3 except one
institution, were only two vertebras are allowed within
one target volume (RSMC).
Disagreement is evident whether epidural involvement
or a small distance between the metastasis and the
spinal cord are contraindications.
Imaging for staging and target definition
There is a good agreement in the imaging modalities and
their technical application for staging and target defini-
tion (table 3). All institutions acquire dedicated CT and
MRI images (a diagnostic MRI is allowed at the UPMC)
for delineation and slice thickness is between 1-2 mm.
Differences, however, are observed in the MRI
sequences and in acquisition of a dedicated planning
FDG-PET.
Target and OAR definition
Similar target volume concepts are used in the five insti-
tutions (table 4). All centers define the gross-tumor
volume (GTV) based on CT and MR imaging, two cen-
ters perform co-registration of a FDG-PET (UPMC,
RSMC). All centers treat the involved vertebras only
without “prophylactic” irradiation of the superior and
inferior vertebra. All institutions use an anatomical target
volume concept where the target volume extends to
uninvolved parts of the vertebras. Additionally, all institu-
tions but one (RSMC) apply safety margins of 2-3 mm.
However, the details of the target volume concepts are
different. Three institutions do always treated the entire
vertebral body and/or the entire posterior elements in
case of involvement (UPMC, UVAMC, RSMC). One
institution has a similar concept, however, differentiates
between the ipsilateral and contralateral posterior
Table 1 Patient specific factors influencing indication for spine SBRT
UHW UPMC UofT UVAMC RSMC
Use of a predictive
scoring system for OS
Yes, Mizumoto Score No Life expectancy ≥ 3
months
Patients with widespread
CNS and systemic disease
are excluded
No
Histology of primary
tumor
No treatment of
highly radiosensitive
histologies
Avoid relatively
radiosensitive histologies
No myeloma unless
previously radiated
No treatment of
radiosensitive histologies
No relevant
factor
Status of primary tumor Yes, part of the
Mizumoto Score
No relevant factor Yes, for estimation of
life expectancy
No relevant factor No relevant
factor
Presence of visceral
metastases
Yes, part of the
Mizumoto Score
No relevant factor Yes, for estimation of
life expectancy
Yes, see above No relevant
factor
Age Yes, part of the
Mizumoto Score
No relevant factor No relevant factor No relevant factor No relevant
factor
Performance status of
patient
Yes, part of the
Mizumoto Score
Exclusion of patients with
extremely poor
performance status
Must be able to
tolerate
immobilization for 45
min.
KPS should be ≥70 KPS must be
≥60
Comorbidities of
patient
No relevant factor No relevant factor No relevant factor No relevant factor No relevant
factor
Interval between
primary tumor and
spinal metastases
No relevant factor No relevant factor No relevant factor No relevant factor No relevant
factor
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approach where the high-dose target volume is defined
as the GTV with a 3 mm safety margin and the low-
dose target volume is the entire vertebra (UHW).
Regarding definition of the OAR spinal cord, all but
one institution (RSMC) define the spinal cord in the
MRI images; the spinal canal is delineated in CT images
at the RSMC. Delineation is performed minimum 1 ver-
tebra superior and inferior to the planning target
volume (PTV) in all institutions and safety margins of
1-2 mm are applied for generation of the planning OAR
spinal cord in all but one institution (UVAMC). On the
level of the cauda equina, all institutions define the the-
cal sac as planning OAR.
Treatment dose and fractionation
Large variability is observed in terms of treatment dose
and fractionation (tables 5). Two institutions treat the
Table 2 Target specific factors influencing indication for spine SBRT
UHW UPMC UofT UVAMC RSMC
Location of
vertebral
metastases (C,
T, L)
No relevant factor No relevant factor No relevant
factor
No relevant factor No relevant factor
Number of
vertebras in
one target
volume
Maximum of 3 levels Maximum of 3 levels Maximum of 3
levels
Maximum of 3 levels Maximum of 2 levels
Extent of
vertebral
metastases
Symptomatic and
progressive cord
compression is
contraindication.
Significant spinal cord
compression associated with
myelopathy is
contraindication.
Symptomatic
cord
compression is
contraindication.
Symptomatic cord compression
is contraindication.
Symptomatic cord
compression is
contraindication.
Epidural
involvement
No relevant factor No relevant factor Surgery if high
grade epidural
involvement
present
Minimum of 2 mm of clearance
between the gross metastastic
disease and the spinal cord
No relevant factor
Stability of
metastatic
vertebra
Surgical opinion sought
first
Instability is preferably
treated with stabilization
procedure
Surgical opinion
sought first
Instability is preferably treated
with stabilization procedure
Instability is
preferably treated
with stabilization
procedure
Lytic or
sclerotic
metastasis
No relevant factor No relevant factor No relevant
factor
No relevant factor No relevant factor
Vertebral
compression
fracture
Symptomatic
compression fracture
are discussed with
neurosurgeons in
advance
Compression fracture
causing kyphosis and pain
will be treated BEFORE
radiosurgery if possible
Surgical opinion
sought first
Compression fracture causing
marked kyphosis or instability
will be treated with stabilization
procedure first
Compression fracture
is preferably treated
with stabilization
procedure
Location of
metastasis
relative to other
organs at risk
No relevant factor No relevant factor No relevant
factor
No relevant factor No relevant factor
Table 3 Imaging for staging & target definition
UHW UPMC UofT UVAMC RSMC
Staging examinations prior to
SBRT/SRS
Oncologic staging is
required
None MRI spine None None
Slice thickness of Planning CT 1.5 mm 1.25 mm 1 mm 1 to 1.5 mm 2 mm
MRI used for target definition Yes Yes Yes Yes Yes
Dedicated Planning MRI Yes No Yes Yes Yes
Slice thickness of planning MRI 2 mm 1.25 mm 1 mm 1.2 mm 3 mm/1.25
mm
MRI sequence used for target
definition,
T1 with and w/o
contrast; T2
T1 with
contrast; T2
T1 w/o contrast volumetric VIBE; T2
volumetric SPACE
T1 with contrast volume
acquisition
T1 with
and w/o
Dedicated FDG-PET/PET-CT for
target definition
Rarely Yes No Rarely Yes
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gery of 16 - 24 Gy (UPMC, UVAMC). One center pre-
fers 2 or 3 fraction radiosurgery (UofT), however, will
treat with single fraction if no epidural disease is evident
and single level disease. Two centers perform fractio-
nated radiosurgery only (UHW, RSMC), and both of
them choose between two fractionation schemas with
estimated life expectancy as selection criterion. Fractio-
nated radiosurgery is performed in 2-10 fractions with
physical doses of 24 - 48.5 Gy. Despite the differences
in dose and fractionation, all but one institution practice
dose prescription to the D90, whereas one institution
uses the ICRU reference point (UofT).
Based on an a/b = 10 Gy, the median 2 Gy-equivalent
dose (EQD2G y )i s5 0G y[ m i n i m u m3 6G y( 3×8G y )
and maximum 68 Gy (1 × 24 Gy)]. As described above,
one institution (UHW) uses a two dose-level concept
with conventional doses in the “elective” parts of the
vertebra (10 × 3 Gy; 5 × 4 Gy) and dose escalated irra-
diation in the involved parts of the vertebra (10 × 4.85
Gy; 5 × 7 Gy).
Spinal cord tolerance doses
No institution varies the spinal cord tolerance based on
cervical, thoracic or lumbar target location. Otherwise,
dosimetric parameters as well as tolerance doses for the
spinal cord and thecal sac were substantially different
between all five institutions (table 6).
Treatment planning
Minor differences are observed in terms of treatment
planning (table 7). All institutions treat their patients at
an Elekta Synergy S linear accelerator equipped with the
Beam Modulator (4 mm leaf width); one center does
also perform spine radiosurgery on different linear
accelerators (UVAMC). Treatment planning system is
Pinnacle (Philips Radiation Oncology Systems, Milpitas,
CA, USA) and intensity modulation is planed using
step-and-shoot IMRT only (UPMC), both IMRT and
VMAT (UHW, RSMC, UofT) and VMAT only
(UVAMC). Technical details are summarized in table 7.
Acceptance criteria for treatment plans vary substan-
tially with all centers stating that no strict criteria exist,
Table 4 Target and organs-at-risk definition
UHW UPMC UofT UVAMC RSMC
Imaging modality,
which is used for GTV
definition
MRI and CT MRI and CT, FDG-
PET if available
MRI and CT CT and MRI CT, MRI and
FDG-PET
Use of an anatomical
target volume concept
Anatomical two dose-level target
volume concept
Anatomical target
volume concept
Anatomical target
volume concept
Anatomical target volume
concept
Anatomical
target
volume
concept
GTV to PTV safety
margin
3 mm 2 mm; 3 mm in the
sacrum.
2 mm 2 mm None
Protocol if PTV overlaps
with the. spinal cord
Two dose-level approach;
The OAR spinal cord is always in the
PTV-elective and is always excluded
from the higher dose PTV-
macroscopic
PTV within 1 mm to
the spinal cord is
excluded from the
PTV
PTV is limited by
the cord or thecal
sac for cauda
equina
If this occurs, we either
operate to resect part of the
tumor or fractionate the
radiation.
GTV drawn
to edge of
OAR
Treatment of the
vertebra superior and
inferior to the
metastatic vertebra
No No No No No
Imaging modality for
definition of the spinal
cord
Spinal cord in MRI Spinal cord in MRI Spinal cord in MRI Spinal cord in MRI Spinal canal
in CT
Delineation of the
spinal cord in cranio-
caudal direction
At least 1 level above and below
PTV
1 level above and
below PTV
At least 1 level
above and below
PTV
1 level above and below
PTV
1 level
above and
below PTV
Safety margins around
the spinal cord in axial
directions
1 mm 1 mm 1.5 mm No 2 mm
anterior
and 1 mm
lateral
Delineation of the
cauda equina
Thecal sac Thecal sac Thecal sac Thecal sac Thecal sac
Delineation other OARs
(e.g. kidney)
No application of safety margins No application of
safety margins
No application of
safety margins
No application of safety
margins
No
application
of safety
margins
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volumes in terms of size, shape and distance to the
spinal cord and other relevant OARs. However, all insti-
tutions agree that PTV coverage is sacrificed until the
dose limits of the critical OARs, especially of the spinal
cord, are fulfilled.
Patient positioning, immobilization and image-guidance
Differences in these steps of spine radiosurgery are small
(table 8). All patients are treated in supine position and
immobilization is performed using thermoplastic head
masks for cervical/upper thoracic lesions and the Body-
FIX for thoracic and lumbar lesions. Daily pre-treatment
image guidance is performed using cone-beam technol-
ogy and set-up errors are corrected in six degrees of
freedom using the robotic HexaPOD couch. Action level
for translational errors is 1 mm in all but one institution
where a larger action level of 2 mm is used (UVAMC);
the action level for rotational errors is 1° in four institu-
tions (UHW, UPMC, UofT, UVAMC), 0.3° in one
Table 5 Doses and fractionation
UHW UPMC UofT UVAMC RSMC
Use of single
fraction
radiosurgery
No, all patients are
treated with either five or
ten fractions
Single fraction
radiosurgery for 95% of
the patients unless very
near to spinal cord.
Majority is treated with
two or three fractions
and specific cases for
single fraction
Majority is treated with a
single fraction of
radiosurgery, occasionally
up to 3 fractions
No, majority are treated
with three fractions with
treatments given one
week apart.
Criteria for
selection of
hypo-
fractionated
regimes
Selection of fractionation
scheme based on life
expectancy using the
Mizumoto Score
Fractionated protocols
in:
1. Epidural disease or
large volume and no
prior irradiation
2. Prior radiation
Fractionated protocols
after prior radiation
If it represents the only
site of disease, we use
30 Gy in 3
Schema 1: #
fractions and
single fraction
dose
Good life expectancy:
30 Gy in 10: PTV-elective
48.5 Gy in 10: PTV
-macroscopic *
16-24 Gy in 1;
Most frequently 17 Gy in
1
20-24 Gy in 1;
Most frequently 20 Gy
in 1
18 to 24 Gy in 1;
Most frequently 20 Gy in
1
24 Gy in 3
Schema 2: #
fractions and
single fraction
dose
Intermediate life
expectancy:
20 Gy in 5: PTV-elective
35 Gy in 5: PTV
-macroscopic *
24 - 27 Gy in 2-3 24 Gy in 3 30 Gy in 3
Schema 3: #
fractions and
single fraction
dose
30 Gy in 3
(for sarcomas)
18 Gy in 3
Dose
prescription
D90 D90 ICRU point D90 D90
* a simultaneous integrated boost (SIB) was used at the UHW with two dose levels to PTV -macroscopic and PTV -elective
Table 6 Spinal cord tolerance doses
Tolerance doses Spinal Cord
Dosimetric parameter Single fraction 3 fractions 5 fractions 10 fractions
UHW Dmax to 0.1 cc 23.75 Gy 35 Gy
UPMC Dmax 11 Gy 18 Gy
UofT Dmax 10 Gy 17.5 Gy 22 Gy
UVAMC D10 10 Gy 15 Gy 20 Gy
RSMC 2 cc 18 Gy
Tolerance doses Cauda equina
Dosimetric parameter Single fraction 3 fractions 5 fractions 10 fractions
UHW Dmax to 0.1 cc 25 Gy 37.5 Gy
UPMC Dmax 12 Gy 18 Gy
UofT Dmax 12 Gy 18 Gy 23 Gy
UVAMC D10 12 Gy 15 Gy 20 Gy
RSMC 2 cc 24 Gy
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verification of the IGRT shift is performed in all institu-
tions and all institutions but one (UHW) perform intra-
treatment cone-beam CT scanning for patient monitor-
ing. A final scan after treatment delivery is performed in
3/5 institutions (UHW, UofT, UVAMC).
Follow-up
Follow up is performed in-house whenever possible in
all institutions; the interval is most frequently every 3
months (table 9). Local tumor control is defined as
tumor shrinkage or no tumor progression in serial ima-
ging, with MRI as the preferable imaging modality. One
Table 7 Treatment planning
UHW UPMC UofT UVAMC RSMC
Treatment planning system Pinnacle Pinnacle Pinnacle Varian Eclipse,
Tomotherapy,
Pinnacle for Elekta
1. Elekta/CMS XiO,
2. Elekta/CMS Monaco
Linac model/MLC leaf width Elekta Synergy S/4 mm Synergy S/4 mm Elekta Synergy S/
4m m
Elekta Synergy S,
Varian Triliogy,
Tomotherapy
Elekta Synergy S/4 mm
IMRT or VMAT treatment
planning
Both IMRT Both VMAT Both
If step-and-shoot IMRT:
number of beams
9 beams on average 9 to 14, but most
are 12 beams
9 - 11 beams 10 beams 10 beams
If VMAT: number of arcs 1-2 arcs Not applicable 1 arc 1-3 arcs 1. one arc 120-140 segments
2. VMAT - 4 arcs - 30-40
segments per arc
Full or partial VMAT arc 360 degrees 360 degrees 360 degrees 360 degree arcs 1. VMAT 350 deg arc
2. VMAT posteriorly biased
arcs, 2 couch kicks
Photon energy 6 or 10 mV depending
on location
6M V 6M V 6M V 6M V
Dosimetric parameters for
plan acceptance
No strict acceptance
criteria.
Usually V90 CTV V80 of at
least 80-90%
No strict
acceptance criteria
Generally D90
Table 8 Patient (re-)positioning and IGRT
UHW UPMC UofT UVAMC RSMC
Treatment prone or
supine
Supine Supine Supine supine Supine
Immobilization device Cervical:
Thermoplastic
mask;
otherwise
BodyFIX
Cervical down to T5:
aquaplast face mask;
otherwise BodyFIX
Cervical down to
T2/3 s frame;
otherwise BodyFIX
Cervical: Thermoplastic
mask;
otherwise BodyFIX
Cervical: Aquaplast mask with
Accuform support secured to
modified S-frame;
otherwise BodyFIX
Image guidance
technology
Cone-beam
CT
Cone-beam CT Cone-beam CT Cone-beam CT Cone-beam CT
Frequency of IGRT Daily Daily Daily Daily Daily
Correction of
rotational set-up errors
Yes - Hexapod
couch
Yes - Hexapod couch Yes - Hexapod
couch
Yes - Hexapod couch Yes - Hexapod couch
Action level for
correction of set-up
errors
1m m
translation,
1 degree
rotation
1 mm translation,
1 degree rotation
1 mm translation,
1 degree rotation
2 mm translation,
1 degree rotation
1 mm translation,
0.3 degree rotation
Second imaging after
couch adjustment
prior to treatment
Yes Yes Yes Yes Yes
Methods for intra-
fractional patient
monitoring
None Cone-beam CT imaging
after one and two thirds
through the treatment
One to two intra-
treatment Cone-
beam CT scans
One intra-fraction cone-
beam CT scan half-way
through treatment
Typical one or two mid
treatment cone-beam CTs
Imaging after
treatment
Yes No Yes Yes No
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evaluation of local tumor control. Pain is assessed in 4/5
institutions using either the Visual Analog Scale (UHW,
UPMC, UVAMC) or NRS-11 (RSMC).
Discussion
This survey observed strong agreement in terms of the
treatment planning and treatment delivery aspects of
spine radiosurgery. Especially safety and quality assur-
ance of this novel treatment technique play a major role
in the methods of all institutions. The following mea-
sures are considered as highly important for as safe-as-
possible practice of spine radiosurgery. 1) Close coop-
eration between radiation oncologists and neurosur-
geons especially in patients with epidural disease, spinal
cord compression and instability; 2) Limitation of the
target volume to maximum 3 vertebras; 3) Dedicated
imaging protocols for target and organ-at-risk definition;
4) Anatomical target volume concepts with application
of proper safety margins for the target volume and the
spinal cord; 5) Highly conformal treatment planning,
daily image-guidance, thorough patient immobilization
and intra-fraction patient monitoring; 6) Close follow-
up with repeated clinical and radiological response
evaluation.
In contrast, three major areas of uncertainty and dis-
agreement were identified: 1) Indications and contra-
indications for spine radiosurgery; 2) treatment dose
and 3) tolerance dose of the spinal cord. These areas
will be discussed more in detail.
Discussion with respect to Indication
Patient factors influencing indication for spine radiosurgery
Several prognostic scoring systems have been developed
for overall survival after conventional, palliative radio-
therapy for painful spine metastases [8,10,22] or meta-
static spinal cord compression [23]. Recently, a recursive
partitioning analysis (RPA) was reported for survival
specific to spine SBRT [24]. The most favorable patients
(Class 1, median OS of 21.1 months) were those with a
time from primary diagnosis (TPD) > 30 months and a
Karnofsky performance status (KPS) > 70, Class 2 was
defined as those with a TPD > 30 months and KPS < 70
or a TPD < 30 months and age < 70 years (median OS
o f8 . 7m o n t h s ) ,a n dC l a s s3w a sa s s o c i a t e dw i t ht h e
poorest outcomes and defined as TPD < 30 months and
age > 70 years (median OS of 2.4 months). One could
argue that spine radiosurgery would seem well indicated
in patients with a longer life expectancy given that pain
response of conventional doses is typically limited to 3 -
6 months (median duration of pain response) and multi-
ple studies reported excellent pain control for a duration
of 12 months after radiosurgery [12,13,25-27].
On the other hand, patients with short life expectancy
could also benefit from spine radiosurgery; however, the
rationale for radiosurgery would then be achievement of
more rapid pain relief. For conventional radiotherapy, a
mean pain response time of 3 weeks was reported by
Van Der Linden et al. [28]. Ryu et al. and Chang et al.
reported a slightly shorter median time to maximum
pain relief of about 2 weeks such that even RPA class 3
patients could benefit from spine radiosurgery [12,25].
Whether this difference in pain relief reaches statistical
significance needs to be demonstrated by a prospective
trial. Until then, spine radiosurgery should be consid-
ered as a viable if not preferable option when rapid pain
relief is required.
Tumor factors influencing indication for spine radiosurgery
Radiosurgical treatment of patients with epidural invol-
vement is a major point of controversy. For tree institu-
tions, epidural involvement was not a relevant factor in
the decision making process for spine radiosurgery,
whereas two institutions either required a clearance
margin between the GTV and the spinal cord or pre-
ferred a surgical procedure prior to radiosurgery. Of
note, the RTOG 0631 trial mandates a margin of 5 mm
between the GTV and the spinal cord. This variation in
indication is most likely explained by the risk of
Table 9 Follow-up and response evaluation
UHW UPMC UofT UVAMC RSMC
Place of follow-up In clinic In clinic In clinic In clinic In clinic
Definition of local control No progression on serial
imaging.
No progression on serial
imaging.
No progression on serial
imaging.
No progression
on serial
imaging.
No progression
on serial
imaging.
Imaging modalities required
for definition of local control
MRI if possible MRI if possible MRI if possible MRI if possible MRI/PET
System for pain scoring Visual analogue scale Visual analogue scale N/A unless of study
then the Brief Pain
Inventory
Visual analogue
scale
NRS-11
Frequency of FU
examinations
Every three months,
every six months after 1
year
1 month, then 3 months,
then 6, 12, and then
yearly.
Every 2-3 months 3 month
intervals for the
first year
Every 3 months
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that 47 - 50% of all local failures after spine radiosurgery
occur at the epidural space [12,27,29]. Sahgal et al.
reported a trend towards local tumor recurrence if the
GTV was within a distance of ≤1 mm to the spinal cord
[30] and the minimum dose delivered to the target
volume was shown as correlated with local tumor con-
trol [31].
A strategy to cope with epidural disease could be the
application of fractionation schemes, which are adapted
to the extent of epidural involvement [32]: single-frac-
tion radiosurgery for targets with a clearance margin
between the tumor and the spinal cord and fractionated
radiosurgery if this clearance margin is violated. This
fractionation could make use of basic radiobiology and
deliver higher biological effective doses to the epidural
tumor. However, the details regarding clearance margin
and number of treatment fractions still have to be
defined.
Dose-fractionation
As previously mentioned, no dose response has been
established for conventional palliative radiotherapy with
doses between 8 Gy in 1 fraction and 40 Gy in 20 frac-
tions. One explanation could be that all tested doses are
well below established thresholds from radical radiother-
apy: e.g. even the “high dose” approach of 40 Gy in 20
fractions would result in tumor control of less than 5%
f o rN S C L C[ 3 3 ] .T h i sh y p o t h e s i si ss u p p o r t e db yt h r e e
studies, which reported a significant dose response rela-
tionship for primary [17,31] and re-irradiation [34] spine
radiosurgery. The Memorial Sloan-Kettering Cancer
Center (MSMCC) group reported excellent local control
of > 95% for a prescription dose of 24 Gy and a mini-
mum dose of > 15.1 Gy; however, the results are based
on a retrospective review of serially dose-escalated
patients and require validation before conclusions can
be drawn. For pain control as primary endpoint, Ryu et
al. reported a lower prescription dose threshold of 14
G y ;t h i sd o s er e s p o n s ew a sn o ts tatistically significant
[25]. It is important to interpret all these treatment
doses in the context of the target and OAR volumes,
which were used in the specific trials. Clinical applica-
tion of any dose specification without detailed knowl-
edge and application of the respective target and OAR
concept cannot be recommended.
Centers in this study use a large rage of fractionations
between single fraction to 10 fractions. Moreover, even
within the single fraction treatment, the applied doses
range between 16 Gy to 24 Gy. In the US, radiosurgery
and stereotactic body radiotherapy are defined as treat-
ment with maximum five fractions. In this study, one
institution uses a 10 fraction approach, which does not
fall under this definition. Nevertheless, we use the term
radiosurgery even for this 10 fraction regimen because
of two reasons: 1) the clinical and technical practice of
the 10 fraction regimen is identical to the regimens
using 1- 5 fractions; 2) using the LQ model, the biologi-
cal effective dose of the 10 fraction regimen is expected
to be at least equivalent to the 1- 5 fractions regimens.
However, the limitations of the LQ model need to be
considered for very high single fraction doses [35].
Tolerance dose of the spinal cord
The third area of uncertainty and disagreement is the
tolerance dose of the spinal cord. There was agreement
between 4/5 institutions that a planning organ-at-risk
should be generated with a safety margin around the
true spinal cord. However, this safety margin varied
between 1 mm around the spinal cord to 2 mm around
the spinal canal. The dosimteric parameter used as dose
threshold varied between Dmax,D 1 0 ,D 0.1 cc and D2c c .
The closest agreement was observed for single fraction
radiosurgery, where dose thresholds of 10 - 11 Gy are
used.
A very low incidence of myelopathy after spine radio-
surgery has been described in the literature, despite
dose escalation and hypo-fractionation. Ryu et al.
observed a myelopathy in 1 out of 86 patients with a
minimum follow-up of one year; these authors recom-
mended a tolerance dose of 10 Gy as D10 [36]. Com-
bined data from Stanford University Medical Center and
University of Pittsburgh Medical Center reported an
incidence of 5 out of 1075 patients, and it was recom-
mended limiting the volume of spinal cord treated
above an 8-Gy equivalent dose [37]. Sahgal et al. col-
lected five cases of myelopathy and compared various
dose volume parameters with 29 patients, who did not
develop myelopathy [38]; all patients were treated with
various radiosurgical fractionations. The thecal sack was
delineated as the planning organ-at-risk volume for all
cases and controls with centralized review of the DVH
data. Doses were converted to 2 Gy-equivalent doses
based on an a/b = 2 Gy to cope with variation of frac-
tionation. The maximum point volume EQD2G ywithin
the thecal sac significantly correlated with the risk of
myelopathy as opposed to the larger volumes investi-
gated (0.1 cc, 2 cc, and 5 cc). An EQD2G ythreshold of
30 - 35 Gy was recommended for 1 - 5 fractions. In
conventionally fractionated radiotherapy, the tolerance
of the spinal cord is usually accepted between 45 - 50
Gy, despite that even a dose of 60 Gy results in a risk of
myelopathy of only approximately 5% [39]. This dis-
agreement between EQD2G ythresholds based on hypo-
fractionation and thresholds based on conventionally
fractionated radiotherapy has recently been confirmed
by Daly et al. [40]. Further research is consequently
required in this field as we do not yet understand the
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Page 9 of 11biologic ramifications of high dose per fraction on the
normal tissues or tumor itself.
Conclusions
Strong agreement in the methods of spine radiosurgery
was observed. In particular, similarities were observed
with safety and quality assurance playing an important
role in the methods of all institutions: cooperation
between neurosurgeons and radiation oncologists in
case selection, dedicated imaging for target- and organ-
at-risk delineation, application of proper safety margins
for the target volume and organs-at-risk, conformal
planning and precise image-guided treatment delivery,
and close clinical and radiological follow-up. In contrast,
three major areas of uncertainty and disagreement were
identified: 1) Indications and contra-indications for
spine radiosurgery; 2) treatment dose and fractionation
and 3) tolerance dose of the spinal cord. Further
research in form of retrospective and especially prospec-
tive studies is required to refine spinal radiosurgery in
terms of safety and efficacy.
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